Want to join the conversation?
$HALO 2Q15 Call: Royalty revenue grew YoverY approx. 278% to $6.4MM in 2Q15 reflecting partnered product sales in the Jan. to March 2015 period. The key driven has been has been the increasing sales of Herceptin SC. On a sequential basis, we saw decline of $400,000 in Royalty revenue due to some initial stockings of HYQVIA.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?